FTO rs3101336: Understanding Genetic Associations with BMI
The rs3101336 variant is a single nucleotide polymorphism located within the FTO gene, which is widely studied for its association with body mass index (BMI) and obesity-related traits. This variant is frequently utilized in genetic research and weight calculators to help identify trends in human body composition.
What each genotype means
Increased obesity risk
This genotype is associated with a higher body mass index and an increased statistical likelihood of obesity compared to those without the risk allele. Research suggests this association is observed from childhood through adulthood and is linked to an increase in fat mass.
This genotype is common, though its prevalence varies significantly across different global populations.
Intermediate obesity risk
Carrying one copy of the risk allele is associated with a modest increase in body mass index compared to individuals who carry no risk alleles. The effect on body weight is typically additive, meaning the impact is generally less pronounced than in individuals with two copies of the risk allele.
This heterozygous genotype is frequently observed in many populations worldwide.
Baseline obesity risk
This genotype is considered the non-risk or baseline profile for this variant. Individuals with this genotype do not carry the specific allele associated with increased body mass index trends in this study context.
This genotype is common in most populations, representing the baseline state for this genetic marker.
What is rs3101336 and Where is it Located?
The rs3101336 variant is a specific genetic marker, or single nucleotide polymorphism (SNP), situated within the FTO (fat mass and obesity-associated) gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The FTO gene is located on chromosome 16 in humans. Research has consistently highlighted that the first intron of the FTO gene is a hotspot for genetic variations that correlate with anthropometric traits. Because rs3101336 sits within this region, it is often analyzed alongside other neighboring SNPs to understand how specific DNA sequences might influence metabolic outcomes. It is important to note that while this SNP is a useful marker for research, it is one of many variations within the FTO region that scientists track to build a more complete picture of the genetic architecture underlying human body weight.
The Role of the FTO Gene
The FTO gene gained significant scientific attention following genome-wide association studies (GWAS) in 2007, which identified it as the first gene unequivocally linked to common forms of human obesity. The gene encodes an enzyme that functions as an m6A RNA demethylase, meaning it plays a role in modifying RNA molecules, which in turn affects various biological and metabolic processes throughout the body. While the exact mechanism by which FTO variants influence body weight is complex, research suggests that the gene is involved in regulating energy balance, including feeding behavior and energy expenditure. Because FTO is expressed in many tissues, including the brain, it is believed to influence how the body processes energy. Understanding the function of FTO helps researchers move beyond simple correlations to investigate the underlying molecular pathways that contribute to differences in BMI across the human population.
Evidence and Statistical Associations
The evidence linking FTO variants to BMI is considered robust within the field of genetic epidemiology. Numerous studies have replicated the association between SNPs in the FTO intron 1 region and increased body mass index. While rs3101336 is used in various genetic calculators to predict BMI trends, it is essential to view these associations as statistical probabilities rather than deterministic outcomes. The effect sizes of individual SNPs are typically modest, meaning that while they contribute to the overall genetic predisposition for weight-related traits, they do not act in isolation. Environmental factors, such as diet and physical activity, play a significant role in modulating these genetic risks. Current research continues to explore how these genetic markers interact with lifestyle factors, emphasizing that genetics provides only one piece of the complex puzzle that determines an individual's body composition and metabolic health.
Population Frequency and Diversity
The FTO variants associated with BMI are common across many global populations. Research has confirmed that these associations are not limited to individuals of European descent; they have been observed in various Asian, African, and African-American cohorts as well. Because these variants are widespread, they are considered common genetic polymorphisms. However, the frequency of specific alleles can vary between different ancestral groups, which is a standard observation in human genetics. This diversity is a critical area of study, as it helps scientists understand the evolutionary history of the FTO gene and ensures that genetic findings are applicable across a broad range of human populations. When interpreting data regarding rs3101336, it is helpful to remember that its prevalence is a reflection of its commonality in the human gene pool rather than an indicator of a rare or unique condition.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs3101336 is primarily intended for educational and research purposes. You can use this information to better understand the current state of obesity genetics and the role that DNA plays in metabolic traits. However, it is vital to recognize that this information cannot be used to diagnose a medical condition or predict an individual's future health with certainty. Genetic markers are not a substitute for professional medical advice, and they do not account for the entirety of an individual's health profile. If you are concerned about your weight, metabolic health, or the potential impact of your genetics on your well-being, you should consult with a qualified healthcare provider or a registered dietitian. They can provide personalized guidance based on your full medical history, lifestyle, and clinical assessments, which are far more informative than any single genetic variant.
How common is this variant?
The rs3101336 variant is common across most global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Does having a specific FTO genotype mean I will be obese?
No, having a specific FTO genotype does not determine your weight. While certain variants are statistically associated with higher BMI, they are only one of many factors, including diet, exercise, and other genes, that influence body composition.
Can I use this genetic information to create a diet plan?
Genetic information is not a substitute for professional nutritional advice. You should consult with a registered dietitian or healthcare provider to create a diet plan tailored to your specific health needs and goals.
Is the FTO gene the only gene that affects weight?
No, body weight is a complex trait influenced by hundreds of different genetic variants, as well as environmental and behavioral factors. FTO is simply one of the most well-studied genes in the context of obesity research.
Where can I find more information about my own genetic data?
If you have taken a genetic test, you should review your results with a genetic counselor or your primary care physician. They can help you interpret your data in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3101336?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.